Add BrightSurf on Google Email

Brigham and Women's Hospital


Phase 3 trial results: mRNA-1273 vaccine continued to be safe and efficacious more than five months after second dose

The mRNA-1273 vaccine has demonstrated sustained efficacy in preventing COVID-19 and severe disease, with consistent high levels of protection observed across various subgroups. Researchers have also found a marginal improvement in reduced cases among those vaccinated more recently during the Delta variant surge.

SourceBrigham and Women's Hospital·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateSep 22, 2021

Study finds racial-ethnic differences in sleep health

A new study from Brigham and Women's Hospital found significant racial-ethnic differences in sleep health, with white adults having the best sleep outcomes and Black adults facing the worst. The research used data from over 1,700 adults and identified factors such as irregular timing and duration, insufficient sleep duration, and high ...

SourceBrigham and Women's Hospital·JournalAmerican Journal of Epidemiology·DateSep 9, 2021

Building a better bioartificial pancreas

Researchers at Brigham and Women's Hospital have designed a convection-enhanced macroencapsulation device that offers improved cell loading capacity, increased cell survival, glucose sensitivity, and timely insulin secretion. The device has the potential to be an autonomous system for minimally invasive treatment of type 1 diabetes.

SourceBrigham and Women's Hospital·JournalProceedings of the National Academy of Sciences·DateSep 6, 2021

Study explores why asthma worsens at night

Researchers investigate how the internal circadian clock affects asthma severity. The study found that people with worse asthma experience greater drops in pulmonary function at night, and exhibit more symptoms-driven bronchodilator use during nighttime hours. This understanding could lead to new treatments for asthma.

SourceBrigham and Women's Hospital·JournalProceedings of the National Academy of Sciences·DateSep 6, 2021

New brain model provides patient-specific Alzheimer’s insights, predictions of cognitive decline

A new brain model developed by researchers at Brigham and Women's Hospital has identified specific forms of amyloid beta-protein and tau protein associated with cognitive decline and Alzheimer's disease. The model uses induced pluripotent stem cell lines from over 50 individuals, providing a powerful experimental system for understandi...

SourceBrigham and Women's Hospital·JournalNeuron·TypeExperimental study·DateSep 1, 2021

Large-scale study finds greater sedentary hours increases risk of obstructive sleep apnea

A large-scale study by Brigham and Women's Hospital found that higher levels of physical activity and lower levels of sedentary behavior are associated with a lower risk of obstructive sleep apnea. The study suggests that promoting an active lifestyle may have substantial benefits for both prevention and treatment of OSA.

SourceBrigham and Women's Hospital·JournalEuropean Respiratory Journal·DateJul 21, 2021

Fifty years of progress in women's health

Major points of progress in women's health since the 1970s include reproductive health advances, improvements in overall well-being throughout life, reduced mortality rates for cardiovascular and cancer diseases in women. Clinical research has improved understanding of conditions disproportionately affecting women, such as autoimmune d...

SourceBrigham and Women's Hospital·JournalNew England Journal of Medicine·DateJun 3, 2021

Study finds women with osteoporosis and low bone density are at increased risk of hearing loss

Researchers from Brigham and Women's Hospital analyzed data from nearly 144,000 women and found a 40% higher risk of moderate or worse hearing loss in those with osteoporosis or low bone density. Bisphosphonates did not alter this risk, suggesting that other factors may contribute to the development of age-related hearing loss.

SourceBrigham and Women's Hospital·JournalJournal of the American Geriatrics Society·DateMay 24, 2021

Original investigation: When drug companies raise list prices, out-of-pocket costs for patients

A new study by Dr. Benjamin Rome and colleagues found that over half of patients experience increases in out-of-pocket costs when drug prices increase, with some patients facing 15% hikes. The study, published in JAMA Network Open, analyzed 79 brand-name drugs and found average out-of-pocket costs rose 3.5% from 2015 to 2017.

SourceBrigham and Women's Hospital·JournalJAMA Network Open·DateMay 4, 2021

Review: Changing views on atherosclerosis

Recent advances in understanding atherosclerosis have shifted traditional views on who is at risk for heart attacks and strokes, highlighting the importance of HDL cholesterol, triglycerides, and inflammation. This review paper explores these changes and their implications for treatment and prevention.

SourceBrigham and Women's Hospital·JournalNature·DateApr 21, 2021

The case for embedding equity into incident command

The authors argue that a structural change to national Hospital Incident Command System (HICS) guidelines is needed to ensure inclusion of an Equity Officer and health equity specialists. This change could help mitigate inequities in hospital responses during disasters, particularly for historically marginalized populations.

SourceBrigham and Women's Hospital·JournalAmerican Journal of Public Health·DateApr 7, 2021